NIAID

Treatment strategies for Middle East respiratory syndrome coronavirus

Author List
Kayvon Modjarrad

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV), an emerging infectious disease of growing global importance, has caused severe acute respiratory disease in more than 1600 people, resulting in almost 600 deaths. The high case fatality rate, growing geographic distribution and vaguely defined epidemiology of this novel pathogen have created an urgent need for effective public health countermeasures, including safe and effective treatment strategies. Despite the relatively few numbers of cases to date, research and development of MERS-CoV therapeutic candidates is advancing quickly. This review surveys the landscape of these efforts and assesses their potential for use in affected populations.

Article Category

MERS-CoV

Article Type

Reviews

Posted Date

09-01-2016

Tables & Figures

Back to top